Nectar Lifesciences Ltd.

₹20.95

+ 0.01 (0.05%)

04:01 pm - close price

BSE: NECLIFE

NSE: NECLIFE

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: -5.07Good: 5

❌

Adjusted EPS

Bad: 3Current: -5.07Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -5.21Good: 20

❌

Current Ratio

Bad: 1Current: 1.21Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -11.23Good: 15

❌

Debt to Total Assets

Bad: 1Current: 29.22Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -5.07Good: 5

❌

Adjusted EPS

Bad: 3Current: -5.07Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -5.21Good: 20

❌

Current Ratio

Bad: 1Current: 1.21Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -11.23Good: 15

❌

Debt to Total Assets

Bad: 1Current: 29.22Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	394.12	397.96	452.17	441.38	359.30
Expenditure+	358.58	371.10	409.98	392.87	319.50
Other Income+	0.47	10.61	0.48	1.47	0.55
Operating Profit	35.54	26.86	42.19	48.50	39.80
Interest	17.62	20.52	24.84	24.16	19.98
Depreciation and Amortization	15.33	15.31	15.37	14.70	15.46
Profit Before Tax	3.06	1.64	2.46	11.11	4.92
Tax+	1.24	0.63	0.89	10.52	1.95
Net Profit	1.82	1.02	1.57	0.59	2.97

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	15432.97	16688.32	15236.69	16840.86	16699.74
Operational Expenses+	14418.44	15102.92	14706.62	15325.33	16995.33
Operating Profit	1014.53	1585.40	530.07	1515.53	-295.59
Other Income	113.83	113.18	530.57	170.57	74.67
OPM %	6.57	9.50	3.48	9.00	-1.77
Depreciation and Amortisation	602.53	569.68	591.19	607.18	623.89
Interest	1120.35	788.10	893.65	896.23	770.53
Profit Before Tax	-847.67	340.80	-424.20	182.69	-1615.34
Tax	-200.90	90.33	-251.30	68.59	-557.58
Net Profit	-732.64	250.47	-241.83	49.95	-1136.81

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	23758.35	23880.32	21686.41	21835.78	19921.83
Liabilities+	23758.35	23880.32	21686.41	21835.78	19921.83

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	213.79	950.05	1336.51	2246.86	1694.38
Cash from Investing Activity	-286.24	166.44	517.04	-170.25	-419.30
Cash from Financing Activity	114.90	-1193.80	-1855.83	-2054.35	-1280.92
Net Cash Flow	42.45	-77.31	-2.28	22.26	-5.84
Opening Cash & Cash Equivalents	212.94	255.39	178.08	175.80	198.06
Closing Cash & Cash Equivalents	255.39	178.08	175.80	198.06	192.22

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	44.91	44.53	44.53	44.53	55.80	55.80	55.80	55.80	55.80	55.80
Public+	55.09	55.47	55.47	55.47	44.20	44.20	44.20	44.20	44.20	44.20
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	76470	71977	69241	69482	66741	58230	59946	60761	60283	61582

Ratios

Reported EPS

Bad: 2Current: -5.07Good: 5

❌

Adjusted EPS

Bad: 3Current: -5.07Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -5.21Good: 20

❌

Current Ratio

Bad: 1Current: 1.21Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -11.23Good: 15

❌

Debt to Total Assets

Bad: 1Current: 29.22Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: -5.07Good: 5

❌

Adjusted EPS

Bad: 3Current: -5.07Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: -5.21Good: 20

❌

Current Ratio

Bad: 1Current: 1.21Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: -11.23Good: 15

❌

Debt to Total Assets

Bad: 1Current: 29.22Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	394.12	397.96	452.17	441.38	359.30
Expenditure+	358.58	371.10	409.98	392.87	319.50
Other Income+	0.47	10.61	0.48	1.47	0.55
Operating Profit	35.54	26.86	42.19	48.50	39.80
Interest	17.62	20.52	24.84	24.16	19.98
Depreciation and Amortization	15.33	15.31	15.37	14.70	15.46
Profit Before Tax	3.06	1.64	2.46	11.11	4.92
Tax+	1.24	0.63	0.89	10.52	1.95
Net Profit	1.82	1.02	1.57	0.59	2.97

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	23758.35	23880.32	21686.41	21835.78	19921.83
Liabilities+	23758.35	23880.32	21686.41	21835.78	19921.83

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	213.79	950.05	1336.51	2246.86	1694.38
Cash from Investing Activity	-286.24	166.44	517.04	-170.25	-419.30
Cash from Financing Activity	114.90	-1193.80	-1855.83	-2054.35	-1280.92
Net Cash Flow	42.45	-77.31	-2.28	22.26	-5.84
Opening Cash & Cash Equivalents	212.94	255.39	178.08	175.80	198.06
Closing Cash & Cash Equivalents	255.39	178.08	175.80	198.06	192.22

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	15432.97	16688.32	15236.69	16840.86	16699.74
Operational Expenses+	14418.44	15102.92	14706.62	15325.33	16995.33
Operating Profit	1014.53	1585.40	530.07	1515.53	-295.59
Other Income	113.83	113.18	530.57	170.57	74.67
OPM %	6.57	9.50	3.48	9.00	-1.77
Depreciation and Amortisation	602.53	569.68	591.19	607.18	623.89
Interest	1120.35	788.10	893.65	896.23	770.53
Profit Before Tax	-847.67	340.80	-424.20	182.69	-1615.34
Tax	-200.90	90.33	-251.30	68.59	-557.58
Net Profit	-732.64	250.47	-241.83	49.95	-1136.81

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	44.91	44.53	44.53	44.53	55.80	55.80	55.80	55.80	55.80	55.80
Public+	55.09	55.47	55.47	55.47	44.20	44.20	44.20	44.20	44.20	44.20
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	76470	71977	69241	69482	66741	58230	59946	60761	60283	61582

Nectar Lifesciences Ltd.

₹20.95

+ 0.01 (0.05%)

04:01 pm - close price

BSE: NECLIFE

NSE: NECLIFE

Industry: Pharmaceuticals & Drugs

House: Private

Overview